menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Swiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth

3 0
21.11.2024
CEO Vas Narasimhan said the Novartis pipeline has "significant potential to rejuvenate our portfolio and support mid-single-digit growth post 2029."

© Fortune


Get it on Google Play